Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joachim Sieper

Showing results (1-10 of 318) with videos related to

Pageof 32
Sort By:
Nature Reviews. Rheumatology|February 4, 2011
Spondyloarthropathies in 2010: new insights into therapy-TNF blockade and beyondJoachim Sieper
Annals of the Rheumatic Diseases|March 31, 2012
How to define remission in ankylosing spondylitis?Joachim Sieper
Nature Clinical Practice. Rheumatology|June 19, 2008
Infliximab therapy for patients with ankylosing spondylitis: on-demand or continuous treatment?Joachim Sieper
Arthritis Research & Therapy|February 24, 2009
Developments in the scientific and clinical understanding of the spondyloarthritidesJoachim Sieper
Der Orthopade|March 2, 2017
Basic therapy in the treatment of arthritisJoachim Sieper
Current Rheumatology Reports|March 16, 2004
Disease mechanisms in reactive arthritisJoachim Sieper
Rheumatology (Oxford, England)|November 19, 2016
New treatment targets for axial spondyloarthritisJoachim Sieper
Current Opinion in Rheumatology|May 9, 2009
Can structural damage be prevented in ankylosing spondylitis?Joachim Sieper
Current Opinion in Rheumatology|June 4, 2011
Editorial comment: spondyloarthritidesJoachim Sieper
Annals of the Rheumatic Diseases|January 29, 2014
Response to H Zeidler's comments on the INFAST studyJoachim Sieper
Pageof 32

Showing results (1-10 of 318) with videos related to

Sort By:
Pageof 32
Nature Reviews. Rheumatology|February 4, 2011
Spondyloarthropathies in 2010: new insights into therapy-TNF blockade and beyondJoachim Sieper
Annals of the Rheumatic Diseases|March 31, 2012
How to define remission in ankylosing spondylitis?Joachim Sieper
Nature Clinical Practice. Rheumatology|June 19, 2008
Infliximab therapy for patients with ankylosing spondylitis: on-demand or continuous treatment?Joachim Sieper
Arthritis Research & Therapy|February 24, 2009
Developments in the scientific and clinical understanding of the spondyloarthritidesJoachim Sieper
Der Orthopade|March 2, 2017
Basic therapy in the treatment of arthritisJoachim Sieper
Current Rheumatology Reports|March 16, 2004
Disease mechanisms in reactive arthritisJoachim Sieper
Rheumatology (Oxford, England)|November 19, 2016
New treatment targets for axial spondyloarthritisJoachim Sieper
Current Opinion in Rheumatology|May 9, 2009
Can structural damage be prevented in ankylosing spondylitis?Joachim Sieper
Current Opinion in Rheumatology|June 4, 2011
Editorial comment: spondyloarthritidesJoachim Sieper
Annals of the Rheumatic Diseases|January 29, 2014
Response to H Zeidler's comments on the INFAST studyJoachim Sieper
Pageof 32